The Nellcor Pulse Oximetry Monitor Interface Cable
FDA Clearance Information
The device was cleared through the FDA 510k pathway on December 15, 2017. Manufactured by Covidien, it is classified as a Class 2 medical device under product code DQA.
What It Is
FDA-Cleared Indications
- For use with compatible Nellcor pulse oximetry sensors and monitors to measure functional oxygen saturation of arterial hemoglobin.
- For monitoring pulse rate derived from the pulse oximetry signal.
- Intended for use in clinical patient-monitoring settings when used with compatible Nellcor equipment.
Clinical Applications
- Continuous oxygen-saturation and pulse-rate monitoring in hospitalized patients.
- Monitoring during postoperative care.
- Monitoring newborn and neonatal patients when used with compatible labeled sensors and monitors.
- Connecting a compatible pulse oximetry sensor to a Nellcor monitor during routine clinical observation.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Compatibility depends on the specific Nellcor monitor, sensor connector and cable model; confirm the equipment labeling before use.
- The interface cable is not itself a pulse oximeter or patient sensor and does not measure oxygen saturation without compatible monitoring equipment.
- Inspect the cable, connectors and insulation before use. Do not use damaged, visibly contaminated or malfunctioning components.
- Follow the manufacturer’s cleaning, disinfection, storage and cable-handling instructions; avoid excessive bending, pulling or tight coiling.
- MRI compatibility is not established from the 510(k) record alone. Confirm the complete monitor, cable and sensor configuration in the manufacturer’s MRI labeling before entering an MRI environment.
Frequently Asked Questions
What are the clinical indications for the Nellcor Pulse Oximetry Monitor Interface Cable?
The device is indicated for monitoring oxygen saturation and heart rate in clinical settings, particularly in neonatal and postoperative care.
What outcomes have been reported in clinical studies?
Studies have reported reliable and accurate readings of oxygen saturation and heart rate, with improved monitoring performance in challenging conditions.
What complications have been reported?
Reported complications include occasional inaccuracies during motion or low perfusion, but no significant adverse events have been documented.